In Beaverton, Oregon, the Pham family is gaining momentum in their quest to secure funding for a groundbreaking gene therapy for their six-year-old son, Raiden Pham, who suffers from a rare genetic disorder. Recent feedback from the U.S. Food and Drug Administration (FDA) has provided renewed hope as the family aims to raise $2 million to support future clinical trials.
The disorder, which affects Raiden’s ability to develop normally, has prompted his parents to seek innovative treatment options. The feedback from the FDA indicates a potential pathway for the gene therapy, which could significantly enhance Raiden’s quality of life. His mother, Linda Pham, expressed optimism, stating that the family feels “a sense of urgency” as they work to turn this feedback into actionable steps toward treatment.
In their effort to raise funds, the Phams are participating in the upcoming Shamrock Run, a popular annual event that attracts thousands of runners and supporters. The run, scheduled for March 17, 2024, not only serves as a platform to raise awareness about Raiden’s condition but also as a crucial fundraising opportunity. Participants can contribute by signing up for the run or by donating directly to Raiden’s treatment fund.
The Pham family’s campaign highlights the challenges many families face when dealing with rare diseases, where treatment options are often limited and expensive. According to the National Institutes of Health, genetic disorders affect millions of people worldwide, yet research and treatment development can be slow and costly.
To support their cause, the Phams have created a dedicated fundraising page, where they share Raiden’s story and the impact of the proposed treatment. Linda emphasizes the importance of community support, stating, “Every dollar brings us closer to a solution.” The family’s goal of $2 million will fund not only the gene therapy but also essential research and trials that could pave the way for future advancements in treating similar conditions.
As the Shamrock Run approaches, the Phams are rallying support from their local community and beyond. They encourage others to join them in their mission, emphasizing that awareness and funding are critical to making progress in medical research for rare genetic disorders. The Pham family’s determination illustrates the profound impact that grassroots efforts can have in driving forward potential treatments for those in need.
Through their relentless pursuit of a cure for Raiden, the Phams exemplify the power of hope and collaboration. As they navigate this challenging journey, they remain committed to not only improving their son’s life but also contributing to the broader fight against genetic disorders.
